United States

Clearside Biomedical is a biopharmaceutical company that specializes in delivering therapies to the back of the eye through the suprachoroidal space. Their main product, XIPERE, is used to treat uveitis macular edema. They are also developing CLS-AX for suprachoroidal injection and CLS-301 for diabetic macular edema and macular degeneration. Clearside Biomedical has collaborations with Bausch Health, Arctic Vision, REGENXBIO, and Aura Biosciences. The company was founded in 2011 and is based in Alpharetta, Georgia.

Google

Quản lý Sản phẩm

Chuyên gia Dữ liệu

Clearside Biomedical

Clearside Biomedical Vị trí đang tuyển

Bạn đã sẵn sàng thăng tiến sự nghiệp? Hãy xem các vị trí đang mở tại Clearside Biomedical.